Mersana Therapeutics mersana.com


Public list: Smart Money VCs (6327) Pharma Startups (4514)

Mersana Therapeutics (NASDAQ: MRSN) is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need. Its most advanced platform, Dolaflexin, has been used to generate a pipeline of proprietary ADC product candidates to address patient populations that are not currently amenable to treatment with traditional ADC-based therapies. Mersana's product candidates include XMT...Show all

Mersana Therapeutics (NASDAQ: MRSN) is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need. Its most advanced p...Show all

Company (IPO / Went public)

Phone: 617-498-0020

Fax:

840 Memorial Drive

Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Mersana Therapeutics $218M Jun 28, 2017
PTC Therapeutics $417.9M Jun 20, 2013
CombiMatrix $56.3M Jul 22, 2008
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Mersana Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 15 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Monoclonal antibodies against her2 epitope and methods of use thereof Jun 18, 2015 Jan 31, 2017 Patent
Protein-polymer-drug conjugates Aug 12, 2014 Feb 09, 2016 Patent
Protein-polymer-drug conjugates Aug 12, 2014 Sep 29, 2015 Patent
Protein-polymer-drug conjugates Jan 16, 2014 Sep 02, 2014 Patent
Protein-polymer-drug conjugates Dec 10, 2012 Aug 26, 2014 Patent
See all 21 patents